Pharmaceutical - Anti-virals, Global

Filter

Current filters:

Anti-viralsGlobal

Popular Filters

1 to 25 of 27 results

New report calls on governments to implement national policies on hepatitis C

New report calls on governments to implement national policies on hepatitis C

25-06-2014

A report published by The Economist Intelligence Unit (EIU) has revealed that many countries around the…

Anti-viralsGlobalHealthcareJanssenPharmaceutical

New treatments to boost hepatitis C market to $19.2 billion by 2016

New treatments to boost hepatitis C market to $19.2 billion by 2016

24-06-2014

The launch of interferon-free regimens is expected to boost the hepatitis C market from $2.9 billion…

Anti-viralsAntiviralsBusiness FinanceCytokinesDatamonitorGilead SciencesGlobalMajorMarkets & MarketingPharmaceuticalSovaldi

Global Fund taps pharmaceutical expertise in China

02-04-2014

The Global Fund is deepening its partnership with China by tapping the expertise of Chinese pharmaceutical…

Anti-viralsAntibiotics and Infectious diseasesChinaGlobalMarkets & MarketingPharmaceuticalProductionRegulation

ViiV Healthcare grants licence to Medicines Patent Pool to improve access to Tivicay

ViiV Healthcare grants licence to Medicines Patent Pool to improve access to Tivicay

02-04-2014

Viiv Healthcare, the HIV/AIDS joint venture of UK pharma giant GlaxoSmithKline, US drugmaker Pfizer and…

Anti-viralsGlobalPharmaceuticalPricingTivicayViiV Healthcare

IFPMA and the Global Fund collaborate to help protect patients from fake medicines

05-12-2013

The International Federation of Pharmaceutical Manufacturers and Associations and the Global Fund to…

Anti-viralsAntibiotics and Infectious diseasesGlobalMarkets & MarketingPharmaceuticalRegulationTropical diseases

Global Fund-proposed shake-up to drug pricing framework risks middle-income countries paying more, says MSF

Global Fund-proposed shake-up to drug pricing framework risks middle-income countries paying more, says MSF

04-12-2013

Ahead of the Global Fund replenishment conference in Washington DC this week, international medical humanitarian…

Anti-viralsAntibiotics and Infectious diseasesGlobalPharmaceutical

Influenza products market to grow at a CAGR of 8% through 2018

14-11-2013

The influenza products market, including vaccines, antivirals and diagnostic products, has been forecast…

Anti-viralsGlobalMarkets & MarketingPharmaceutical

In wake of Tivicay approval, MSF asks, "when will people in developing countries have access?"

13-08-2013

As the US Food and Drug Administration approved the new HIV drug Tivicay (dolutegravir) late Monday (The…

Anti-viralsdolutegravirGlobalHealthcarePharmaceuticalPricingTivicayViiV Healthcare

UNITAID market power results in price cuts of up to 80% for HIV/AIDS, TB and malaria products

30-05-2013

UNITAID's approach to transform health product markets has delivered price reductions of up to 80% for…

Anti-viralsAntibiotics and Infectious diseasesGenericsGlobalHealthcarePharmaceuticalPricingTropical diseases

Medicines Patent Pool and ViiV Healthcare collaborate to treat pediatric HIV

28-02-2013

The Medicines Patent Pool (MPP) this week announced the launch of a new collaboration with ViiV Healthcare…

AbacavirAnti-viralsGenericsGlobalPatentsPharmaceuticalViiV Healthcare

Need for global policy innovation to tackle the "Silent Pandemic" that is hepatitis C, says EIU report

16-01-2013

There is an urgent need for countries around the world to develop strategies to tackle head-on the growing…

Anti-viralsBiotechnologyGlobalHealthcareMarkets & MarketingPharmaceutical

H1N1 pandemic fears to maintain lofty US flu vaccination levels, says GlobalData

08-01-2013

US demand for influenza vaccines will remain high in the coming decade, following a post-flu pandemic…

Anti-viralsGlobalMarkets & MarketingNorth AmericaPharmaceuticalVaccines

Sales of antiretroviral agents for HIV will decline slightly over next decade

18-12-2012

Major-market sales of antiretroviral (ARV) agents for HIV will decline slightly over the next decade,…

Anti-viralsBiotechnologydolutegravirGenericsGlaxoSmithKlineGlobalMarkets & MarketingPharmaceuticalRegulationViiV Healthcare

Middle-income countries flex muscles to overcome patents in face of unaffordable drug prices

29-07-2012

Middle-income countries are increasingly taking measures to overcome the patents that price drugs out…

Anti-viralsGenericsGlobalPatentsPharmaceuticalPricing

More than 150 ARVs available through PEPFAR for global HIV/AIDS relief

24-07-2012

US Food and Drug Administration Commissioner Margaret Hamburg says that the agency has approved or tentatively…

Anti-viralsGenericsGlobalPharmaceuticalRegulation

Merck & Co in-licenses Chimerix antiviral; Fiocruz to make ARVs in Africa

24-07-2012

USA-based Chimerix, a venture-funded biotech focused on developing novel oral antivirals, has announced…

Anti-viralsChimerixCMX001CMX157FiocruzGlobalLicensingMarkets & MarketingMerck & CoPharmaceuticalRest of the World

DNDi and Cipla to develop 4-in-1 pediatric antiretroviral drug combination

24-07-2012

Coinciding with the XIX International AIDS Conference in Washington DC, the Drugs for Neglected Diseases…

Anti-viralsCiplaGenericsGlobalPharmaceuticalResearch

Domestic HIV funding outpaces international investments

19-07-2012

A new report by the Joint United Nations Program on HIV/AIDS (UNAIDS) shows that domestic funding for…

Anti-viralsFinancialGlobalHealthcarePharmaceutical

Public health groups launch global campaign against Abbott Labs’ monopoly on critical AIDS medicine

11-11-2011

A global campaign to challenge US health care major Abbott Laboratories’ (NYSE: ABT) monopolistic…

Abbott LaboratoriesAnti-viralsGenericsGlobalKaletra CapsulesPharmaceuticalPricing

Superior combo therapies to sustain HIV/AIDS market growth despite major patent expiries

19-10-2011

The HIV/AIDS therapeutics market is a growing therapy sector, with the USA dominating in terms of revenues.…

Anti-viralsGlobalMarkets & MarketingPatentsPharmaceutical

UNAIDS calls for urgent analysis and more research on hormonal contraceptives and HIV infection risk

06-10-2011

The Joint United Nations Programme on HIV/AIDS (UNAIDS) is following with concern data from recent studies…

Anti-viralsGlobalHealthcarePharmaceuticalReproductive

1 to 25 of 27 results

Back to top